Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03095352
Title Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hope Rugo, MD
Indications

triple-receptor negative breast cancer

breast cancer

Therapies

Carboplatin + Pembrolizumab + Trastuzumab

Carboplatin

Carboplatin + Trastuzumab

Carboplatin + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.